NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ValiRx plc (LSE: VAL)

 
VAL Technical Analysis
1
As on 29th Oct 2024 VAL STOCK Price closed @ 1.60 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VALSTOCK Price

Open 1.60 Change Price %
High 1.70 1 Day N/A N/A
Low 1.55 1 Week 0.00 0.00
Close 1.60 1 Month 0.00 0.00
Volume 113467 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
LSE UK Most Active Stocks
TRP 0.03 %
MSMN 0.04 %
CPX 0.17 %
LLOY 54.54 %
UKOG 0.03 %
PREM 0.04 %
DKE 0.15 0.00%
NNN 0.09 50.00%
DMTR 0.03 0.00%
BOIL 0.08 %
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
VENC 139.60 65.21%
0UTC 0.41 51.85%
NNN 0.09 50.00%
NNN 0.09 50.00%
MCLS 1.68 46.09%
0ZU5 0.07 40.00%
0RNL 0.87 31.82%
0J03 3.10 30.80%
0I5R 0.13 30.00%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
VAL
Daily Charts
VAL
Intraday Charts
Whats New @
Bazaartrend
VAL
Free Analysis
 
VAL Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
VAL Forecast October 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
VAL Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
VAL Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
VAL Other Details
Segment EQ
Market Capital 33988208.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VAL Address
VAL
 
VAL Latest News
 
Your Comments and Response on ValiRx plc
 
VAL Business Profile
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc has collaboration agreement with Oncolytika Limited and Black Cat Bio Limited to develop and evaluate VAL201 for patients suffering a hyperimmune response to Coronavirus SARS-CoV2 infection. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom. Address: Stonebridge House, Hatfield, United Kingdom, CM22 7BD
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service